| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 99.11B | 99.36B | 88.04B | 92.41B | 85.13B | 90.02B |
| Gross Profit | 12.56B | 12.03B | 9.95B | 8.80B | 10.23B | 14.11B |
| EBITDA | 7.80B | 7.54B | 6.20B | 4.82B | 6.36B | 10.31B |
| Net Income | 4.19B | 3.89B | 2.74B | 1.13B | 3.30B | 5.18B |
Balance Sheet | ||||||
| Total Assets | 77.58B | 83.72B | 76.04B | 78.77B | 78.30B | 79.42B |
| Cash, Cash Equivalents and Short-Term Investments | 15.06B | 7.75B | 13.44B | 8.17B | 12.81B | 14.04B |
| Total Debt | 6.78B | 6.71B | 6.81B | 6.91B | 7.01B | 5.01B |
| Total Liabilities | 37.13B | 42.02B | 35.51B | 39.11B | 37.80B | 38.63B |
| Stockholders Equity | 40.45B | 41.69B | 40.53B | 39.66B | 40.50B | 40.79B |
Cash Flow | ||||||
| Free Cash Flow | 1.15B | -2.31B | 8.02B | -2.67B | 945.00M | -2.59B |
| Operating Cash Flow | 1.44B | -971.00M | 10.95B | 2.38B | 4.65B | 1.14B |
| Investing Cash Flow | -304.00M | -1.34B | -2.87B | -5.03B | -3.67B | -3.62B |
| Financing Cash Flow | -795.00M | -3.38B | -2.82B | -2.02B | -2.23B | 2.34B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
75 Outperform | ¥52.68B | 7.30 | ― | 3.78% | 11.81% | 52.35% | |
73 Outperform | ¥56.75B | 10.18 | ― | 4.90% | 4.91% | 57.89% | |
68 Neutral | ¥48.69B | 4.67 | ― | 2.26% | 12.93% | 98.16% | |
67 Neutral | ¥71.76B | 11.22 | ― | 2.56% | 1.71% | 14.20% | |
65 Neutral | ¥55.85B | 9.11 | ― | 2.84% | 15.45% | 43.95% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
60 Neutral | ¥62.67B | 19.35 | ― | 1.57% | 11.01% | 231.83% |